Results 31 to 40 of about 6,262,677 (213)
Hydronephrosis in autosomal dominant polycystic kidney disease [PDF]
An 18-year-old patient with autosomal dominant polycystic kidney disease (ADPKD) was enrolled in a clinical study testing a novel drug therapy to retard disease progression. He reported chronic intermittent right-sided flank pain that began 2 years earlier and was attributed to ADPKD at that time.
Kistler, A D +3 more
openaire +4 more sources
Caroli′s syndrome in a post renal transplant patient: Case report and review of the literature
Caroli′s syndrome is characterized by bile duct ectasia in association with hepatic fibrosis. It is usually transmitted in an autosomal recessive fashion and has been well documented to be associated with autosomal recessive polycystic kidney disease and
Muhammad Z Bawany +2 more
doaj +1 more source
Background Autosomal dominant polycystic kidney disease is defined as an inherited disorder characterized by renal cyst formation due to mutations in the PKD1 or PKD2 gene, whereas tuberous sclerosis complex is an autosomal dominant neurocutaneous ...
Kenji Gonda +15 more
doaj +1 more source
Hypertension in Autosomal Dominant Polycystic Kidney Disease
Al-Khader Abdullah
doaj +2 more sources
Autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kiney disease is a hereditary systemic disorder, characterized by the developement of cysts, mainly in the kidney and liver, also with gastrointestinal and cardiovascular abnormalities. It affects 4 to 6 million people wordwide and accounts for end-stage renal disease in 7-10% of dialysis patients.
openaire +2 more sources
Angiogenesis in autosomal-dominant polycystic kidney disease [PDF]
Autosomal-dominant polycystic kidney disease (ADPKD) is a genetic disorder that is responsible for approximately 10% of all cases of end-stage renal disease (ESRD). It is characterized by the formation of epithelial cell cysts, an increase in the extracellullar matrix, and vascular alterations believed to be the result of compression by the cysts.
Bello-Reuss, Elsa +2 more
openaire +2 more sources
Educational Case: Autosomal Dominant Polycystic Kidney Disease
The following fictional case is intended as a learning tool within the Pathology Competencies for Medical Education (PCME), a set of national standards for teaching pathology.
Ryan L. Frazier BS +1 more
doaj +1 more source
Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations [PDF]
Laia Sans-Atxer,1 Dominique Joly2 1Department of Nephrology, Hospital del Mar, Institut Mar for Medical Research, Barcelona, Spain; 2Faculty of Medicine, Université Paris-Descartes, Assistance Publique-Hôpitaux de Paris, Service de Né ...
Joly D +5 more
core +1 more source
Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a polycystin-2 (TRPP2)-dependent manner. [PDF]
Identifying and characterising potential new therapeutic agents to target cell proliferation may provide improved treatments for neoplastic disorders such as cancer and polycystic ...
Baines, D +20 more
core +1 more source
What Is Autosomal Dominant Polycystic Kidney Disease?
International audienceThis JAMA Patient Page describes autosomal dominant polycystic kidney disease, its signs and symptoms, diagnosis, and treatment ...
Alam, Ahsan +5 more
core +1 more source

